HWM
HighMark Wealth Management Portfolio holdings
AUM
$205M
1-Year Return
18.44%
This Quarter Return
+8.26%
1 Year Return
+18.44%
3 Year Return
+65.97%
5 Year Return
+111.28%
10 Year Return
–
AUM
$183M
AUM Growth
+$16.5M
(+9.9%)
Cap. Flow
+$4.85M
Cap. Flow
% of AUM
2.66%
Top 10 Holdings %
Top 10 Hldgs %
70.41%
Holding
625
New
37
Increased
151
Reduced
119
Closed
30
Top Buys
| 1 |
FNA
Paragon 28, Inc.
FNA
|
$2.82M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$1.19M |
| 3 |
NVIDIA
NVDA
|
$785K |
| 4 |
Evolent Health
EVH
|
$579K |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$406K |
Top Sells
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$509K |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$434K |
| 3 |
iShares Russell 2000 ETF
IWM
|
$347K |
| 4 |
Protolabs
PRLB
|
$282K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$182K |
Sector Composition
| 1 | Healthcare | 13.01% |
| 2 | Financials | 4.64% |
| 3 | Technology | 4.06% |
| 4 | Industrials | 1.41% |
| 5 | Consumer Discretionary | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Barclays
BCS
$69.1B
| $2.91K | ﹤0.01% |
239
+68
| +40% | +$828 |
|
452
Autoliv
ALV
$9.58B
| $2.89K | ﹤0.01% |
31
| – | – |
|
453
Neurocrine Biosciences
NBIX
$14.3B
| $2.88K | ﹤0.01% |
25
-15
| -38% | -$1.73K |
|
454
Icon
ICLR
$13.6B
| $2.87K | ﹤0.01% |
10
| – | – |
|
|
SW
455
Smurfit Westrock plc
SW
$24.5B
| $2.83K | ﹤0.01% |
+57
| New | +$2.83K |
|
456
On Holding
ONON
$14.9B
| $2.81K | ﹤0.01% |
56
-11
| -16% | -$552 |
|
|
SOWG
457
Sow Good
SOWG
$9.13M
| $2.81K | ﹤0.01% |
240
| – | – |
|
458
Lucid Motors
LCID
$5.66B
| $2.65K | ﹤0.01% |
75
| – | – |
|
459
Dow Inc
DOW
$17.4B
| $2.56K | ﹤0.01% |
47
+1
| +2% | +$55 |
|
460
CenterPoint Energy
CNP
$24.7B
| $2.55K | ﹤0.01% |
87
+1
| +1% | +$29 |
|
461
Evercore
EVR
$12.3B
| $2.53K | ﹤0.01% |
10
| – | – |
|
462
Energizer
ENR
$1.96B
| $2.52K | ﹤0.01% |
79
+1
| +1% | +$32 |
|
463
Coca-Cola Europacific Partners
CCEP
$40.4B
| $2.51K | ﹤0.01% |
32
-17
| -35% | -$1.33K |
|
464
Madison Square Garden
MSGS
$4.71B
| $2.5K | ﹤0.01% |
12
| – | – |
|
465
BP
BP
$87.4B
| $2.5K | ﹤0.01% |
39
-40
| -51% | -$2.56K |
|
466
International Paper
IP
$25.7B
| $2.49K | ﹤0.01% |
51
| – | – |
|
|
ROIC
467
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.48K | ﹤0.01% |
157
+1
| +0.6% | +$16 |
|
468
Direxion Daily S&P 500 Bull 3x Shares
SPXL
$5.49B
| $2.46K | ﹤0.01% |
+15
| New | +$2.46K |
|
469
Rentokil
RTO
$12.8B
| $2.44K | ﹤0.01% |
98
+11
| +13% | +$273 |
|
470
Novartis
NVS
$251B
| $2.42K | ﹤0.01% |
21
-15
| -42% | -$1.73K |
|
471
Trane Technologies
TT
$92.1B
| $2.33K | ﹤0.01% |
6
+2
| +50% | +$777 |
|
472
Ingles Markets
IMKTA
$1.34B
| $2.27K | ﹤0.01% |
30
| – | – |
|
473
Merck
MRK
$212B
| $2.26K | ﹤0.01% |
20
| – | – |
|
474
Motorola Solutions
MSI
$79.8B
| $2.25K | ﹤0.01% |
5
| – | – |
|
475
Direxion Daily Small Cap Bull 3x Shares
TNA
$2.24B
| $2.22K | ﹤0.01% |
+50
| New | +$2.22K |
|